Kelly Montoya
Family · Denver, CONPI 1396105433
Payments from drug & device makers
Across 103 payments — averaging $20.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$315
- Boston Scientific$193
- Boehringer Ingelheim$180
- Exact Sciences$139
- Johnson & Johnson$131
- AstraZeneca$122
- plus $997 from 22 others
What the payments were for
- Food & beverage$2,076100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 19 | $315 |
| Boston Scientific | 1 | $193 |
| Boehringer Ingelheim | 8 | $180 |
| Exact Sciences | 6 | $139 |
| Johnson & Johnson(2 entities) | 7 | $131 |
| AstraZeneca | 7 | $122 |
| AbbVie | 5 | $118 |
| Novo Nordisk | 6 | $116 |
| Pfizer | 6 | $103 |
| Merck | 6 | $97 |
| Amgen(2 entities) | 5 | $93 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $66 |
| Jazz Pharmaceuticals Inc. | 2 | $43 |
| Astellas Pharma US Inc | 2 | $42 |
| Amarin Pharma, Inc. | 2 | $36 |
| Amneal Pharmaceuticals LLC | 2 | $34 |
| Eisai Inc. | 2 | $32 |
| GSK | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Dynavax Technologies Corporation | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| IBSA Pharma Inc. | 1 | $17 |
| Clarus Therapeutics Inc. | 2 | $15 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
How this compares
$2,076 in reported general payments places this provider in the 85th percentile of 2,182 family providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 29 | $33,300 |
| Rosuvastatin Calcium | 39 | $443 |
| Atorvastatin Calcium | 63 | $421 |
| Levothyroxine Sodium | 34 | $379 |
| Duloxetine Hcl | 11 | $354 |
| Losartan Potassium | 26 | $197 |
| Bupropion XlBupropion Hcl | 11 | $180 |
| Lisinopril | 25 | $178 |
| Gabapentin | 12 | $142 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $137 |
| Azithromycin | 26 | $136 |
| Metformin Hcl ErMetformin Hcl | 11 | $113 |
| Amlodipine Besylate | 17 | $104 |
| Tamsulosin Hcl | 12 | $81 |
| Metformin Hcl | 13 | $79 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $315 | $33,30029 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $34 | $37934 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,182 family providers in Colorado.
Other family in Denver
- Katie NadingDenver$28K
- Randall McDavidDenver$26K
- Kyle OdvodyDenver$24K
- Naser Kalani YazdDenver$15K
- Jennine StaffordDenver$15K
- Kara RobertsonDenver$10K
- Katherine RiedlerDenver$8K
- Laura GrahamLakewood$1.6M
- Corinne YoungColorado Springs$272K
- Margaret MachaffieColorado Springs$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.